{"answers":{"affected":"It affects 2 products.","exploited":"There is no known exploitation of CVE-2018-14787 in the wild and no public exploit code.","fix":"No fix has been published for CVE-2018-14787 yet. Limit exposure of the affected software until one is available.","what":"CVE-2018-14787 is a high-severity vulnerability in Philips IntelliSpace Cardiovascular (ISCV) products, published on 22 Aug 2018. It can only be exploited from the same machine or local network, with no action from the victim."},"fix_prompt":"Check this codebase for CVE-2018-14787 and fix it if it is affected.\n\nWhat it is: CVE-2018-14787 is a high-severity vulnerability in Philips IntelliSpace Cardiovascular (ISCV) products, published on 22 Aug 2018. It can only be exploited from the same machine or local network, with no action from the victim.\nExploitation: There is no known exploitation of CVE-2018-14787 in the wild and no public exploit code.\n\nAffected product: Philips IntelliSpace Cardiovascular (ISCV) products. No package-level version data is available, so check the vendor advisory linked from the reference page.\n\nTask:\n1. Search the dependency manifests and lockfiles (for example package.json, package-lock.json, requirements.txt, poetry.lock, uv.lock, pom.xml, build.gradle, go.mod, Cargo.lock, Gemfile.lock) and any Dockerfiles for the affected packages, including transitive dependencies.\n2. If an affected version is in use, upgrade it to the fixed version for its release line with the project's package manager, so the lockfile is regenerated. Prefer the smallest upgrade that fixes it.\n3. If there is no fix, or the upgrade would break the build, do not guess: explain the risk and the safest workaround instead.\n4. Run the tests and summarise what changed and why.\n5. If nothing in the project is affected, say so and change nothing.\n\nReference: https://insights.sbomify.com/CVE-2018-14787/ (Markdown: https://insights.sbomify.com/CVE-2018-14787/index.md)","id":"CVE-2018-14787","markdown":"https://insights.sbomify.com/CVE-2018-14787/index.md","name":"CVE-2018-14787","record":{"aliases":["GHSA-29jf-w9mr-r2xp"],"analysis":{"component_type":"desktop_application","fix_type":"patch","impacts":["code_execution","privilege_escalation"],"network_reachable":"adjacent_or_local","non_default_config":false,"product_category":"Philips ISCV","requires_auth":"low_privilege","summary":"An attacker with escalated privileges can execute arbitrary code with local administrative permissions by accessing writable executable folders in Philips ISCV products.","user_interaction":"not_required","vuln_class":"privilege_escalation"},"analysis_generated_by":"qwen3.8-flash-next","assigner":"icscert","cpe":[{"product":"intellispace_cardiovascular","vendor":"philips"},{"product":"xcelera","vendor":"philips"}],"cvss":{"score":7.8,"severity":"high","source":"nvd","vector":"CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H","version":"3.1"},"cwes":[{"id":"CWE-269","name":"Improper Privilege Management"}],"description":"In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior), an attacker with escalated privileges could access folders which contain executables where authenticated users have write permissions, and could then execute arbitrary code with local administrative permissions.","ecosystems":[],"exploits":{"exploitdb":0,"first_seen":null,"github_poc":0,"max_poc_stars":null,"metasploit":0,"nuclei":0,"refs":[],"tier":"none_known"},"has_fix":null,"headline":"Privilege escalation in IntelliSpace Cardiovascular (ISCV) products","id":"CVE-2018-14787","indexable":true,"kev":null,"kind":"cve","links":{"ecosystem":null,"product":null,"products":[],"type":"privilege_escalation","year":"2018"},"n_packages":0,"n_references":2,"next":{"headline":"Memory corruption in Alpha5 Smart Loader","id":"CVE-2018-14788"},"packages":[],"prev":{"headline":"Missing authorization in Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA","id":"CVE-2018-14786"},"products":["IntelliSpace Cardiovascular (ISCV) products"],"published":"2018-08-22","related":[{"cvss_score":7.2,"headline":"Information disclosure in n/a","id":"CVE-2017-14111","kev_date_added":null,"published":"2017-11-17"},{"cvss_score":6.7,"headline":"Privilege escalation in IntelliSpace Cardiovascular (ISCV) products","id":"CVE-2018-14789","kev_date_added":null,"published":"2018-08-22"},{"cvss_score":6.3,"headline":"Auth bypass in n/a","id":"CVE-2018-5438","kev_date_added":null,"published":"2018-03-20"}],"sources":[{"class":"attribution","licence":"CVE Terms of Use (MITRE)","name":"CVE List","prefix":"CVE"},{"class":"attribution","licence":"US public information, NVD API terms","name":"NVD"},{"class":"attribution","licence":"CWE Terms of Use","name":"CWE (MITRE)"},{"class":"attribution","licence":"FIRST CVSS licence","name":"CVSS (FIRST)"}],"ssvc":{"automatable":null,"exploitation":null,"technical_impact":null},"state":"PUBLISHED","updated":"2024-09-16","vendors":["Philips"]},"summary":"An attacker with escalated privileges can execute arbitrary code with local administrative permissions by accessing writable executable folders in Philips ISCV products.","url":"https://insights.sbomify.com/CVE-2018-14787/"}